|  In addition to adopting new CDC guidelines, IDPH is 
			bolstering the data on its COVID-19 dashboard to provide additional 
			information to help communities respond to changes in the course of 
			the virus. 
 Among the new data that has been or will be shared on the IDPH 
			COVID-19 dashboard are the following:
 
  Updated data on vaccination rates to reflect the full population 
			eligible as eligibility continues to evolve.
 
  The number of people admitted to the hospital with a COVID-19 
			diagnosis.
 
  More detailed data on hospitalizations, including information 
			about vaccination status in those who are hospitalized.
 
 Test and case positivity rates were seen as a good way to monitor 
			the level of community spread early in the pandemic, said IDPH 
			Acting Director Amaal Tokars. At this stage, now that we have 
			vaccines and effective therapies available, it is more useful to 
			rely on data that indicates the case rate, disease severity and the 
			level of strain on healthcare system to guide our public health 
			recommendations.
 
			
			 The changes adopted by the CDC mean that states will no longer be 
			required to report negative antigen test (rapid test) results  and 
			are only required to report negative PCR and NAAT (Nucleic Acid 
			Amplification Test) results that were performed in certified labs. 
			In addition, the widespread use of at-home tests means that national 
			testing data is not as comprehensive or representative of 
			population-based testing as it was before the introduction of 
			at-home tests.
 The CDC announced in March that is relying on these three metrics to 
			determine the community level of COVID-19 and to classify it as low, 
			medium or high:
 
  Total new COVID-19 cases per 100,000 population in the past 7 
			days.
 
  New COVID-19 admissions per 100,000 population in the past 7 days.
 
  The percent of staffed inpatient beds occupied by COVID-19 
			patients.
 
 IDPH officials note that case rates for COVID-19 are now slowly 
			rising in many areas of the state. However, hospitalizations and 
			deaths continue to remain low at this time.
 Given that the spread of COVID-19 is increasing, 
			it is critically important that those who are at high risk for 
			serious illness take the following precautions:
  Get vaccinated and stay up-to-date on recommended booster shots to 
			protect yourself, your loved ones and friends.
  If you are in an area with rising COVID-19 
			infections, wear a mask if entering indoor spaces with other people 
			present and consider avoiding large gatherings. 
			
			 
            [to top of second column] | 
            
			 
             Stick to well-ventilated areas if you are not 
			wearing a mask indoors around other people.
  If you feel flu-like symptoms, self-isolate and stay home from 
			work as well as social gatherings; and obtain a test as quickly as 
			possible.
 
  If you test positive, talk to your provider immediately so you can 
			get COVID-19 treatment within five days of starting to feel sick. 
			Also, communicate about the positive result with any persons you 
			have been in close contact within two days of falling sick or 
			testing positive.
 
  Continue to frequently wash your hands and cover coughs and 
			sneezes.
 
 In addition, on March 29, the Centers for Disease Control and 
			Prevention (CDC) issued updated guidance that authorized a second 
			booster dose for certain segments of the population at least four 
			months after the first booster dose. This applies to adults over 50 
			years of age, and to immunocompromised individuals (those with a 
			poor ability to fight infections) over 12 years old. The CDC also 
			recommended a second booster dose with an mRNA vaccine for all those 
			who received the Johnson & Johnson vaccine for both their primary 
			dose and their first booster, four months after their first booster 
			dose. Those who already received an mRNA booster dose after their 
			initial Johnson and Johnson primary vaccine do not need an 
			additional booster unless they are either over the age of 50 years 
			or immunocompromised.
 
 The State of Illinois remains strongly positioned to respond in the 
			event of a new COVID-19 surge. The State stockpile of tests is 
			nearly fully replenished, with more than 1.5 million rapid tests on 
			hand, and a half a million more on the way in the coming weeks. The 
			State has also instructed hospitals, schools, and long term care 
			facilities to consider their current testing capacity and take all 
			preparations necessary. The State is also supporting pharmacies and 
			healthcare providers in efforts to increase their inventories of the 
			various FDA-authorized treatments in case of another surge. In 
			Illinois, 99.4% of state residents have a pharmacy or clinic 
			providing or dispensing treatment within 20 miles of where they 
			live.
 
             
            For more information, go to:
			
			https://dph.illinois.gov/covid19.html. 
 Vaccination is the key to ending this pandemic. To find a COVID-19 
			vaccination location near you, go to www.vaccines.gov.
 
 The federal government recently established a new website that 
			provides an all-purpose toolkit that provides information on how to 
			obtain masks, treatment, vaccines and testing resources for all 
			areas of the country at: 
			https://www.covid.gov/.
 
            [Illinois Office of Communication and 
			Information] |